International Biotechnology Trust’s ChemoCentryx, Inc. CCXI Stock Holding History

International Biotechnology Trust’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,000	Closed	-$121K	–	84
2022 Q2	$121K	Sell	3,000 -33,100	-92%	-$730K	1.26%	25
2022 Q1	$1.31M	Hold	36,100	–	–	0.3%	51
2021 Q4	$1.31M	Sell	36,100 -58,200	-62%	-$2.04M	0.29%	53
2021 Q3	$7.13M	Buy	94,300 +36,200	+62%	+$564K	1.72%	20
2021 Q2	$4.04M	Sell	58,100 -230,500	-80%	-$5.68M	1.07%	24
2021 Q1	$14.8M	Buy	288,600 +33,000	+13%	+$1.99M	3.91%	11
2020 Q4	$15.8M	Buy	255,600 +232,000	+983%	+$13.3M	4.31%	9
2020 Q3	$1.29M	Sell	23,600 -168,000	-88%	-$9.04M	0.42%	36
2020 Q2	$10.5M	Buy	191,600 +1,600	+0.8%	+$87.1K	3.48%	11
2020 Q1	$7.63M	Buy	+190,000	New	+$8.07M	3.48%	10

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

International Biotechnology Trust's CCXI Position: Q3 2022 in Review

International Biotechnology Trust sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 3,000 shares — an estimated $121K sold.

International Biotechnology Trust first reported a position in CCXI in Q1 2020 and held it in 10 quarters. The position peaked at $15.8M in Q4 2020. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

International Biotechnology Trust reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
International Biotechnology Trust sold 3,000 ChemoCentryx, Inc. shares in Q3 2022, an estimated $121K.
International Biotechnology Trust first reported a position in ChemoCentryx, Inc. in Q1 2020 and held it in 10 quarters.
International Biotechnology Trust's ChemoCentryx, Inc. position peaked at $15.8M in Q4 2020.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on International Biotechnology Trust's 13F filing for Q3 2022, filed 8 Nov 2022.